Trial intelligence / Profile preview

Acyline + Testosterone + DMPA for Male Contraception (HOP 5 Sub-Study)

NCT00156650Phase 2Completed

Sponsor
University of Washington
Start
Dec 2004
Primary completion
Jul 2005
Modality
Peptides, Small Molecules
Countries
1
01

Overview

Phase 2 trial of acyline in contraception (2 arms), sponsored by University of Washington. Primary endpoint: Intratesticular hormone levels at 1 year. Started Dec 2004; status: completed.

02

Drugs

acyline
03

Conditions

contraception

Beyond the preview

Go deeper on NCT00156650.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00156650.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call